This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

5n13

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Revision as of 11:55, 26 August 2020

Second Bromodomain (BD2) from Candida albicans Bdf1 in the unbound form

Structural highlights

5n13 is a 1 chain structure. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

[BDF1_CANAL] Transcription factor involved in the expression of a broad class of genes including snRNAs. Required for sporulation and DNA-damage repair. Prevents the spreading of SIR silencing at telomeres and protects histone H4, but not H3, from deacetylation (By similarity).

Publication Abstract from PubMed

Invasive fungal infections cause significant morbidity and mortality among immunocompromised individuals, posing an urgent need for new antifungal therapeutic strategies. Here we investigate a chromatin-interacting module, the bromodomain (BD) from the BET family of proteins, as a potential antifungal target in Candida albicans, a major human fungal pathogen. We show that the BET protein Bdf1 is essential in C. albicans and that mutations inactivating its two BDs result in a loss of viability in vitro and decreased virulence in mice. We report small-molecule compounds that inhibit C. albicans Bdf1 with high selectivity over human BDs. Crystal structures of the Bdf1 BDs reveal binding modes for these inhibitors that are sterically incompatible with the human BET-binding pockets. Furthermore, we report a dibenzothiazepinone compound that phenocopies the effects of a Bdf1 BD-inactivating mutation on C. albicans viability. These findings establish BET inhibition as a promising antifungal therapeutic strategy and identify Bdf1 as an antifungal drug target that can be selectively inhibited without antagonizing human BET function.

Selective BET bromodomain inhibition as an antifungal therapeutic strategy.,Mietton F, Ferri E, Champleboux M, Zala N, Maubon D, Zhou Y, Harbut M, Spittler D, Garnaud C, Courcon M, Chauvel M, d'Enfert C, Kashemirov BA, Hull M, Cornet M, McKenna CE, Govin J, Petosa C Nat Commun. 2017 May 18;8:15482. doi: 10.1038/ncomms15482. PMID:28516956^[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Mietton F, Ferri E, Champleboux M, Zala N, Maubon D, Zhou Y, Harbut M, Spittler D, Garnaud C, Courcon M, Chauvel M, d'Enfert C, Kashemirov BA, Hull M, Cornet M, McKenna CE, Govin J, Petosa C. Selective BET bromodomain inhibition as an antifungal therapeutic strategy. Nat Commun. 2017 May 18;8:15482. doi: 10.1038/ncomms15482. PMID:28516956 doi:http://dx.doi.org/10.1038/ncomms15482

1 Structural highlights
2 Function
3 Publication Abstract from PubMed
4 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5n13"

@@ Line 1: / Line 1: @@
 ==Second Bromodomain (BD2) from Candida albicans Bdf1 in the unbound form==
-<StructureSection load='5n13' size='340' side='right' caption='[[5n13]], [[Resolution|resolution]] 1.20&Aring;' scene=''>
+<StructureSection load='5n13' size='340' side='right'caption='[[5n13]], [[Resolution|resolution]] 1.20&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[5n13]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5N13 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5N13 FirstGlance]. <br>
+<table><tr><td colspan='2'>[[5n13]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5N13 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5N13 FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5n13 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5n13 OCA], [http://pdbe.org/5n13 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5n13 RCSB], [http://www.ebi.ac.uk/pdbsum/5n13 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5n13 ProSAT]</span></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5n13 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5n13 OCA], [http://pdbe.org/5n13 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5n13 RCSB], [http://www.ebi.ac.uk/pdbsum/5n13 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5n13 ProSAT]</span></td></tr>
 </table>
 == Function ==
@@ Line 22: / Line 22: @@
 __TOC__
 </StructureSection>
+[[Category: Large Structures]]
 [[Category: Champlebouxm, M]]
 [[Category: Chauvel, M]]

5n13

From Proteopedia

Revision as of 11:55, 26 August 2020

Second Bromodomain (BD2) from Candida albicans Bdf1 in the unbound form

Structural highlights

Function

Publication Abstract from PubMed

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox